Phys Chem Chem Phys 2008, 10:303–310 CrossRef 14 Krueger A, Steg

Phys Chem Chem Phys 2008, 10:303–310.CrossRef 14. Krueger A, Stegk J, Liang Y, Lu L, Jarre G: Biotinylated nanodiamond: simple and efficient functionalization of detonation diamond. Langmuir 2008, 24:4200–4204.CrossRef 15. O’brien RW, Ward DN: Electrophoresis

of a spheroid with a thin double layer. J Colloid Interface Sci 1988, 121:402–413.CrossRef 16. Cheng XK, Kan AT, Tomson MB: Naphthalene adsorption and desorption from aqueous C60 fullerene. J Chem Eng Data 2004, 49:675–683.CrossRef 17. Brooks PC, Montgomery AM, Cheresh DA: Use of the 10-day-old chick embryo model for studying angiogenesis. Methods Mol Biol 1999, 129:257–269. 18. Blacher S, Devy L, Hlushchuk R, Larger E, Lamandé N, Burri P, Corvol P, Djonov V, Foidart JM, Noël A: Quantification of angiogenesis in the chicken chorioallantoic membrane (CAM). Image Analysis Dynamin inhibitor & Stereology 2005, 24:169–180.CrossRef 19. Ribatti D, Vacca A, Roncali L, Dammacco F: The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol 1996, 40:1189–1197. 20. Flamme I: Is extraembryonic angiogenesis check details in the chick

embryo controlled by the endoderm? A morphology study. Anat Embryol (Berl) 1989, 180:259–272.CrossRef 21. Javerzat S, Franco M, Herbert J, Platonova N, Peille AL, Pantesco V, De Vos J, Assou S, Bicknell R, Bikfalvi A, Hagedorn M: Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system. PLoS One 2009, 4:e7856.CrossRef 22. Bakowicz-Mitura K, Bartosz G, Mitura S: Influence

of diamond powder particles on human gene expression. Surf Coatings Technol 2007, 201:6131–6135.CrossRef 23. Bhattacharya E, Mukherjee P, Xiong Z, Atala A, Soker S, Mukhopadhyay D: Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Racecadotril Nano Lett 2004, 4:2479–2481.CrossRef 24. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S: Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005, 11:3530–3534.CrossRef 25. Wang K, Ruan J, Song H, Zhang J, Wo Y, Guo S, Cui D: Biocompatibility of graphene oxide. Nanoscale Res Lett 2011, 6:8. 26. Liao KH, Lin Y, Macosko CW, Blebbistatin Haynes CL: Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces 2011, 3:2607–2615.CrossRef 27. Jiang Q, Li JC, Wilde G: The size dependence of the diamond-graphite transition. J Phys Condens Matter 2000, 12:5623.CrossRef 28. Wang J, Morita I, Onodera M, Murota SI: Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide. J Cell Physiol 2002, 190:238–250.CrossRef 29. Duval M, Bédard-Goulet S, Delisle C, Gratton JP: Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells. J Biol Chem 2003, 278:20091–20097.

Acknowledgements This work was financially supported by the Natur

Acknowledgements This work was financially supported by the Natural Science Foundation of China (51101078 and 61103148), the National Basic Research Program of China (2012CB933101), and the Fundamental Research Funds for the Central Universities (lzujbky-2013-29). References 1. Terris BD, Thomson T: Nanofabricated

and self-assembled magnetic structures as data storage media. J Phys D: Appl Phys 2005, 38:R199-R222.CrossRef 2. Zhu JG, Zheng YF, Prinz GA: Ultrahigh density vertical magnetoresistive random access memory. J Appl Phys 2000, 87:6668.CrossRef 3. Akerman J: Toward a universal memory. Science 2005, 308:508–510.CrossRef 4. Allwood DA, Xiong G, Faulkner CC, PRIMA-1MET concentration Atkinson D, Petit D, Cowburn RP: Magnetic domain-wall logic. Science 2005, 309:1688–1692.CrossRef 5. Vargas NM, Allende S, Leighton B, Escrig J, Mejía-López J, Altbir D, Schuller IK:

Asymmetric magnetic dots: a way to control magnetic properties. J Appl Phys 2011, 109:073907.CrossRef 6. Palma JL, Morales-Concha C, Leighton B, Altbir D, Escrig J: Micromagnetic simulation of Fe asymmetric nanorings. J Magn Magn Mater 2012, 324:637.CrossRef 7. Leighton B, Pereira A, Escrig J: Reversal modes in asymmetric Ni nanowires. J Magn Magn Mater 2012, 324:3829.CrossRef MDV3100 molecular weight 8. Leighton B, Vargas NM, Altbir D, Escrig J: Tailoring the magnetic properties of Fe asymmetric nanodots. J

Magn Magn Mater 2011, 323:1563.CrossRef 9. Jaafar M, Yanes R, Perez de Lara D, Chubykalo-Fesenko O, Asenjo A, Gonzalez EM, Anguita JV, Vazquez M, Vicent JL: Control of the chirality and polarity of magnetic vortices in triangular nanodots. Phys Rev B 2010, 81:054439.CrossRef 10. Gaididei selleck compound Y, Sheka DD, Mertens FG: Controllable switching of vortex chirality in magnetic nanodisks by a field pulse. Appl Phys Lett 2008, 92:012503.CrossRef 11. Konoto M, Yamada T, Koike K, Akoh H, Arima T, Tokura Y: Formation and control of magnetic vortex chirality in patterned micromagnet arrays. J Appl Phys 2008, 103:023904.CrossRef 12. Kim DO, Lee DR, Choi Y, Metlushko V, Park J, Kim JY, Lee KB: Inducing vortex formation in multilayered circular dots using remanent curves. Appl Phys Lett 2012, 101:192404.CrossRef 13. Szary P, Petracic O, Brüssing F, Ewerlin M, Zabel H: Indication of vortex stabilization and buckling in circular shaped magnetic nanostructures. J Appl Phys 2010, 107:113922.CrossRef 14. Tanase M, Petford-Long AK, AZD3965 manufacturer Heinonen O, Buchanan KS, Sort J, Nogués J: Magnetization reversal in circularly exchange-biased ferromagnetic disks. Phys Rev B 2009, 79:014436.CrossRef 15. Yamada K, Kasai S, Nakatani Y, Kobayashi K, Kohno H, Thiaville A, Ono T: Electrical switching of the vortex core in a magnetic disk. Nat Mater 2007, 6:270–273.CrossRef 16.

jejuni were used for this analysis, the human clinical isolate 11

jejuni were used for this analysis, the human clinical isolate 11168 and the chicken isolate 331. Free glycan (H-disaccharide, A-blood group antigen and α1-2 mannobiose) were added to the media at a final concentration of 100 μM just prior to addition of the bacteria. Acknowledgements This work was partially funded by and CJD and LHT are supported by a Queensland State Government, Department of Science, Information Technology, Innovation and the Arts Research Partnerships Program. GT is supported by a Griffith University Postgradute Research Scholarship. Electronic supplementary material Additional file 1: Table of Glycans. (DOC 132 KB) References see more 1. Smith DC, Lord JM, Roberts

LM, Johannes L: Glycosphingolipids as toxin receptors. Semin Cell Dev Biol 2004,15(4):397–408.PubMedCrossRef 2. Lehmann F, Tiralongo E, Tiralongo J: Sialic acid-specific lectins: occurrence, specificity and function. Cell Mol Geneticin Life Sci 2006,63(12):1331–1354.PubMedCrossRef 3. Day CJ, Tiralongo J, Hartnell RD, Logue CA, Wilson JC, von Itzstein M, Korolik V: Differential carbohydrate recognition by Campylobacter jejuni strain 11168: influences of temperature and growth conditions. PLoS One 2009,4(3):e4927.PubMedCrossRef 4. Day CJ, Semchenko EA, Korolik V: Glycoconjugates play a key role in campylobacter jejuni infection: interactions between host and pathogen. Front Cell Infect Microbiol 2012, 2:9.PubMedCrossRef 5. Newburg DS, Ruiz-Palacios GM, Morrow AL: Human milk Thalidomide glycans protect

infants against enteric pathogens. Annu Rev Nutr 2005, 25:37–58.PubMedCrossRef 6. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS: Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 2005,135(5):1304–1307.PubMed 7. click here Yamaoka Y: Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J Gastroenterol 2008,14(27):4265–4272.PubMedCrossRef 8. Juge N: Microbial adhesins to gastrointestinal mucus.

Trends Microbiol 2012,20(1):30–39.PubMedCrossRef 9. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, et al.: Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002,297(5581):573–578.PubMedCrossRef 10. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH, Hill GR, Korolik V, McGuckin MA: MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 2007,117(8):2313–2324.PubMedCrossRef 11. Varki A: Multiple changes in sialic acid biology during human evolution. Glycoconj J 2009,26(3):231–245.PubMedCrossRef 12. Le Pendu J: Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. Adv Exp Med Biol 2004, 554:135–143.PubMedCrossRef 13. Suzuki N, Laskowski M Jr, Lee YC: Phylogenetic expression of Galalpha1–4Gal on avian glycoproteins: glycan differentiation inscribed in the early history of modern birds.

While viable indicator bacteria provide useful baseline resistanc

While viable indicator bacteria provide useful baseline resistance

data, the capacity for bacteria to transfer or acquire antibiotic resistance genes stresses the importance of considering the total level of encoded resistance in a bacterial community [7]. In addition, some bacteria may be intrinsically resistant to a class of antimicrobials, limiting their usefulness in predicting the relevance of resistance expression to dissemination of the trait [8]. DNA-based methods Selleckchem PD98059 are increasingly being used to monitor the level of resistance genes in environmental samples and have an advantage in that they allow for analysis of community resistance, including bacteria that are un-culturable in the laboratory. Metagenomic studies have been used to examine the prevalence of tetracycline and erythromycin resistance genes in fecal, soil, lagoon and ground water samples in agricultural environments that use antimicrobials [8–11]. However, in some instances these studies lacked detailed information on antimicrobial exposure or the extent to which these GS-9973 ic50 determinants persisted over time. In a previous study, we analyzed AR Escherichia coli in artificial fecal deposits originating from animals with a known history of antimicrobial-use [12]. We observed a treatment effect on AR genes encoded by E. coli displaying a similar phenotype and also differences

in survival of AR genotypes within treatments. In the AZD6738 concentration present study, we sought to extend those findings by determining if differential persistence of AR genes (tet, erm, sul) cAMP within the microbial community occurs as a result of the subtherapeutic use of antimicrobials in beef cattle production. Results Antimicrobial resistance genes in fecal deposits from cattle fed subtherapeutic levels of antimicrobial growth promoters were investigated over a 175-day period. The subtherapeutic antimicrobials were selected based on the commonality of use in the industry and included chlortetracycline (44 ppm, A44), chlortetracycline plus sulfamethazine (both at 44 ppm, AS700), tylosin phosphate

(11 ppm, T11) or no antibiotic supplementation (control). Resistance genes were quantified by real-time PCR. In addition, differences in bacterial populations, represented by 16S-rRNA, were analyzed by real-time PCR and DGGE. A detailed description of the complete feedlot experiment has been previously published [12]. 16S-rRNA genes Copies of 16S-rRNA genes were affected by an interaction between time of fecal pat exposure and treatment (P = 0.0001, Figure 1). Generally, the concentration of 16S-rRNA increased in all treatments by day 56. Concentrations decreased thereafter, but by day 175, were not different from the concentrations on day 7. Figure 1 Quantification of 16S-rRNA in cattle fecal deposits under field conditions.

When the annealing temperature is above 800°C, diffraction peaks

When the annealing temperature is above 800°C, diffraction peaks of (111), (222), and (333) from the cubic phase of the ZnAl2O4 spinel structure appear in the XRD patterns. This result shows Bortezomib mouse that the multiple crystalline ZnAl2O4 film is synthesized by the high temperature annealing process above 800°C. The surface morphologies of the samples annealed at PXD101 clinical trial different temperatures of 700, 800, 1,000, and 1,100°C were observed by SEM, as shown in Figure  12a,b,c,d. The film annealed at relatively low temperature

of 700°C for 0.5 h had a smooth surface morphology as shown in Figure  12a. At annealing temperature of 800°C, the film starts to crystallize, with significant grain boundaries emerge on the surface, as shown in Figure  12b. The crystalline grains in the film grow up with increasing annealing temperature from 1,000 to 1,100°C, as shown in Figure  12c,d. Figure 11 XRD spectra of the ZnO/Al 2 O 3 composite Sotrastaurin films after annealed at different temperatures. Figure 12 SEM images of the ZnO/Al 2 O 3 composite films with optimized ZnO/Al 2 O 3 monocycle ratio of 1:1. Samples were annealed at 700°C (a), 800°C (b), 1,000°C (c), and

1,100°C (d), respectively. Conclusions AZO and ZnAl2O4 films were prepared by alternating atomic layer deposition (ALD) of ZnO/Al2O3 laminates using DEZn, TMA and water. A deposition temperature of 150°C was selected for the ZnO/Al2O3 composite films. The growth per cycle, structure, electrical, and optical properties of the ZnO/Al2O3 laminates were studied at different Al concentration, which was controlled by varying the cycle ratio of ZnO/Al2O3 from 1:2 to 50:1. It is shown that the growth Vorinostat clinical trial rate of the ZnO is reduced during the ALD of ZnO/Al2O3 multilayers

due to the etching of the ZnO surface layer during exposure to TMA precursor in Al2O3 cycle. Conductive transparent AZO films were obtained at low Al doping concentration with the minimum resistivity of 2.38 × 10−3 Ω·cm and transmittance above 80% in the visible range. The PL spectroscopy in conjunction with XRD reveals that pure ZnAl2O4 film was synthesized from the composite with alternative monocycle of ZnO and Al2O3 deposited by precise ALD technology. SEM and XRD studies indicate that the crystalline ZnAl2O4 films can be synthesized at annealing temperature from 800°C to 1,100°C. Acknowledgments One of the authors would like to acknowledge Dr. Jun Qian for assisting in X-ray diffraction analysis. This work was supported by Chinese ‘973’ project (no. 2013CB632102) and National Natural Science Foundation of China NSFC (nos. 61275056 and 60977036). References 1. Nomura K, Ohta H, Takagi A, Kamiya T, Hirano M, Hosono H: Room-temperature fabrication of transparent flexible thin-film transistors using amorphous oxide semiconductors. Nature 2004, 432:488–492.CrossRef 2.

It shows that the number of apoptotic cells

It shows that the number of apoptotic cells increase as the radiation dose is escalated from 0 to 8 Gy. Figure 5 TUNEL assay for S180 transplant sarcoma after irradiation. In pathological sections of

S180 sarcoma after irradiation (× 100), the black arrow indicates the TUNEL positive apoptotic cells. It shows that the number of apoptotic cells increases as radiation of 8 Gy is delivered comparing to that of the 0 Gy control. The AZD6738 cost degree of tracer uptake in tumor correlated well with the apoptotic rate evaluated by TUNEL assay. In EL4 lymphoma, the apoptotic rate significantly increased as the dose increased from 2 to 8 Gy (Table 2). In S180 sarcoma, the apoptotic rate measured by TUNEL assay was significantly higher in the 8 Gy group than that in 0 Gy group (Table 3). Similar to the biodistribution results, Akt inhibitor the corresponding apoptotic rate measured by TUNEL in the EL4 lymphoma was also significantly higher than that of the S180 sarcoma for both 0 Gy (P = 0.017) and 8 Gy (P < 0.001). The increment of apoptotic cells at 8 Gy relative to 0 Gy was less in 10058-F4 cost S180 sarcoma than that in the EL4 lymphoma, which agrees well with the TAVS imaging results. As shown in Figure 6, when data from all tumor

samples were combined (EL4 and S180 tumors were not distinguished from each other), it could be observed that the number of apoptotic cells (abscissa) was linearly correlated with the percentage of99mTc-HYNIC- annexin V taken up by all tumors Urease (ordinate), with a correlation coefficient (r) of 0.892 and a corresponding P value of < 0.001. These results

indicated that the degree of radiation induced apoptosis in tumor could be represented by the99mTc-HYNIC- annexin V activity taken up in EL4 and S180 tumors. However, there are systematic deviations of points from the line, e.g., a sigmoid between 0.08 and 0.28 on the ordinate followed by a more gradual linear increase between 2.8 and 4. Figure 6 Correlation of TUNEL positive cells and 99m Tc-HYNIC-annexin V uptake in EL4 and S180 tumors. The plot shows the number of apoptotic cells (TUNEL positive) is linearly correlated with the uptake of the radio-labeled Annexin-V in the murine transplant tumors, showing that the Annexin-V imaging may illustrate different degrees of radiation induced apoptosis. Tumor regression after irradiation To evaluate the tumor response to radiation, the regression of EL4 lymphoma and S180 sarcoma in mice after single-dose irradiation with 8 Gy was observed (Figure 7). Without irradiation (0 Gy), the EL4 lymphoma grew with a daily increment of 0.1 cm in diameter and reached 5.1 cc (SD = 1.1) 13 days after tumor inoculation in mice. After a single 8 Gy irradiation, the EL4 lymphoma began to shrink on the second day and the tumor underwent significant necrosis on the 6th day after irradiation and disappeared completely on day 13.

Rigby CE, Pettit JR, Baker MF, Bentley AH, Salomons MO, Lior H: F

Rigby CE, Pettit JR, Baker MF, Bentley AH, Salomons MO, Lior H: Flock infection and transport as sources of Salmonellae in broiler chickens and carcasses. Can J Comp Med 1980, 44:328–337.PubMed 14. Wales A, Breslin M, Carter B, Sayers R, Davies R: A longitudinal study of environmental Salmonella contamination in caged and free-range layer flocks. Avian Pathol 2007, 36:187–197.PubMedCrossRef 15. Li X, Payne JB, Santos FB, Levine JF, Anderson KE, Sheldon BW: Salmonella populations

and prevalence in layer feces from commercial high-rise houses and characterization of the Salmonella isolates by serotyping, antibiotic resistance analysis, selleck chemicals llc and pulsed field gel electrophoresis. Poult Sci 2007, 86:591–597.PubMed 16. Capita R, Alonso-Calleja C, Prieto M: Prevalence of Salmonella enterica G418 serovars and genovars from chicken carcasses in slaughterhouses in Spain. J Appl Microbiol 2007, 103:1366–1375.PubMedCrossRef 17. Vaeteewootacharn

K, Sutra S, Vaeteewootacharn S, Sithigon D, Jamjane O, Chomvarin C, Hahnvajanawong C, Thongskulpanich N, Thaewnongiew K: Salmonellosis and Omipalisib chemical structure the food chain in Khon Kaen, northeastern Thailand. Southeast Asian J Trop Med Public Health 2005, 36:123–129.PubMed 18. Chiu CH, Su LH, Chu CH, Wang MH, Yeh CM, Weill FX, Chu C: Detection of Multidrug-Resistant Salmonella enterica Serovar Typhimurium Phage Types DT102, DT104, and U302 by Multiplex PCR. J Clin Microbiol 2006, 44:2354–2358.PubMedCrossRef 19. De La Torre E, Zapata D, Tello M, Mejía W, Frías N, García-Peña FJ, Mateu EM, Torre E: Several Salmonella enterica subsp. enterica serotype 4,5,12:i: Etofibrate phage types isolated from swine samples originate from serotype

Typhimurium DT U302. J Clin Microbiol 2003, 41:2395–2400.PubMedCrossRef 20. McQuiston JR, Parrenas R, Ortiz-Rivera M, Gheesling L, Brenner F, Fields PI: Sequencing and comparative analysis of flagellin genes fliC, fljB , and flpA from Salmonella . J Clin Microbiol 2004, 42:1923–1932.PubMedCrossRef 21. Mortimer CK, Peters TM, Gharbia SE, Logan JM, Arnold C: Towards the development of a DNA-sequence based approach to serotyping of Salmonella enterica . BMC Microbiol 2004, 4:31.PubMedCrossRef 22. Yoshida C, Franklin K, Konczy P, McQuiston JR, Fields PI, Nash JH, Taboada EN, Rahn K: Methodologies towards the development of an oligonucleotide microarray for determination of Salmonella serotypes. J Microbiol Methods 2007, 70:261–271.PubMedCrossRef 23. Cardinale E, Gros-Claude JDP Rivoal K, Rose V, Tall F, Mead GC, Salvat G: Epidemiological analysis of Salmonella enterica ssp. enterica serovars Hadar, Brancaster and Enteritidis from humans and broiler chickens in Senegal using pulsed-field gel electrophoresis and antibiotic susceptibility. J Appl Microbiol 2005, 99:968–977.PubMedCrossRef 24. Gaul SB, Wedel S, Erdman MM, Harris DJ, Harris IT, Ferris KE, Hoffman I: Use of pulsed-field gel electrophoresis of conserved Xba I fragments for identification of swine Salmonella serotypes. J Clin Microbiol 2007, 45:472–476.

J Chem Technol Biot 2009,84(2):151–157 CrossRef 18 Bhambure R, B

J Chem Technol Biot 2009,84(2):151–157.CrossRef 18. Bhambure R, Bule M, Shaligram N, Kamat M, Singhal R: Extracellular biosynthesis of gold nanoparticles using Aspergillus niger – its characterization and stability. Chem Eng Technol 2009,32(7):1036–1041.CrossRef 19. Das SK, Das AR, Guha AK: Gold nanoparticles: microbial synthesis and application selleck compound in water hygiene management. Langmuir 2009,25(14):8192–8199.CrossRef 20. Kalishwaralal K, Deepak V, Pandian Ram Kumar S, Gurunathan S: Biological synthesis of gold nanocubes from Bacillus licheniformis . Bioresour Technol

2009,100(21):5356–5358.CrossRef 21. Kalishwaralal K, Deepak V, Pandian SRK, Kottaisamy M, BarathManiKanth S, Kartikeyan B, Gurunathan S: Biosynthesis of silver and gold nanoparticles using Brevibacterium casei . Colloids Surf B: Biointerf 2010,77(2):257–262.CrossRef 22. Klaus T, Joerger R, Olsson E, Granqvist CG: Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci USA 1999,96(24):13611–13614.CrossRef 23. Jin Y, Li H, Bai J: Homogeneous selecting of a GSK1904529A mw quadruplex-binding ligand-based gold nanoparticle fluorescence resonance energy transfer assay. Anal Chem 2009,81(14):5709–5715.CrossRef 24. Narayanan

KB, Sakthivel N: Biological synthesis of metal nanoparticles by microbes. Adv Colloid Interface Sci 2010,156(1–2):1–13.CrossRef 25. Beveridge TJ, Lazertinib in vivo Murray RG: Sites of metal deposition in the cell wall of Bacillus subtilis . J Bacteriol 1980,141(2):876–887. 26. Gurunathan S, Kalishwaralal K, Vaidyanathan R, Venkataraman D, Pandian SR, Muniyandi J, Hariharan N, Eom SH: Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli . Colloids Surf B: Biointerf 2009,74(1):328–335.CrossRef

27. Nair B, Pradeep T: Coalescence MycoClean Mycoplasma Removal Kit of nanoclusters and formation of submicron crystallites assisted by Lactobacillus strains. Cryst Growth Des 2002,2(4):293–298.CrossRef 28. Husseiny MI, El-Aziz MA, Badr Y, Mahmoud MA: Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa . Spectrochim Acta A 2007,67(3–4):1003–1006.CrossRef 29. He S, Guo Z, Zhang Y, Zhang S, Wang J, Gu N: Biosynthesis of gold nanoparticles using the bacteria Rhodopseudomonas capsulata . Mater Lett 2007,61(18):3984–3987.CrossRef 30. Bhainsa KC, D’Souza SF: Extracellular biosynthesis of silver nanoparticles using the fungus Aspergillus fumigatus . Colloids Surf B: Biointerf 2006,47(2):160–164.CrossRef 31. Kathiresan K, Manivannan S, Nabeel MA, Dhivya B: Studies on silver nanoparticles synthesized by a marine fungus, Penicillium fellutanum isolated from coastal mangrove sediment. Colloids Surf B: Biointerf 2009,71(1):133–137.CrossRef 32. Philip D: Biosynthesis of Au, Ag and Au–Ag nanoparticles using edible mushroom extract. Spectrochim Acta A Mol Biomol Spectrosc 2009,73(2):374–381.CrossRef 33.

PubMed 31 Rapoport E, Le Pendu J: Glycosylation alterations of c

PubMed 31. Rapoport E, Le Pendu J: Glycosylation alterations of cells in late phase apoptosis from colon carcinomas. Glycobiology 1999, 9: 1337–1345.CrossRefPubMed 32. Azuma Y, Ito M, Taniguchi A, Matsumoto K: Expression

of cell surface Lewis x and y antigens and FUT4 mRNA is increased in Jurkat cells undergoing Daporinad solubility dmso apoptosis. Biochim Biophys Acta 2004, 1672: 157–163.PubMed 33. Dettke M, Pálfi G, Pursch E, Fisher MV, Loibner H: Increased expression of the blood group-related Lewis Y antigen on synovial fluid granulocytes of patients with arthritic joint diseases. Rheumatology 2001, 40: 1033–1037.CrossRefPubMed 34. Miyake M, Hakomori SI: A specific cell surface glycoconjugate controlling cell motility: Evidence by functional selleck chemicals antibodies that ACP-196 molecular weight inhibit cell motility and tumor cell metastasis. Biochemistry 1991, 30: 3328–3334.CrossRefPubMed 35. Croce MV, Colussi AG, Price MR, Segal-Eiras A: Expression of tumor associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study. Anticancer Res 1997, 17: 4287–4292.PubMed 36. Klinger M, Farhan H, Just H, Drobny H, Himmler G, Loibner H, Mudde GC, Freissmuth M, Sexl V: Antibodies directed against Lewis y antigen inhibit signaling of Lewis-Y modified ErbB receptors. Cancer Res 2004, 64: 1087–1093.CrossRefPubMed 37. Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM,

Campbell PL, Volin MV, Bäcker AE, Koch AE: Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol 2000, 164: 4868–4877.PubMed 38. Kusinska R, Kordek R, Pluciennik E, Bednarek AK, Piekarsk JHi, Potemski P: Does vimentin help to delineate the so-called ‘basal type breast cancer’? Journal of Experimental & Clinical Cancer Research 2009, 28: 118.CrossRef 39. Hanisch FG, Stadie TR, Deutzmann F, Peter-Katalinic J: MUC1 glycoforms in breast cancer-cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation. Eur J Biochem 1996, 236: 318–327.CrossRefPubMed 40. Kudryashov V, Glunz PW, Williams LJ, Hintermann S, Danishefsky

SJ, Lloyd KO: Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis y conjugates http://www.selleck.co.jp/products/Adrucil(Fluorouracil).html in mice. Proc Natl Acad Sci USA 2001, 98: 3264–3269.CrossRefPubMed 41. Livingston PO, Ragupathi G: Cancer vaccines targeting carbohydrate antigens. Hum Vaccin 2006, 2: 137–143.PubMed 42. von Mensdorff-Pouilly S, Petrakou E, Kenemans P, van Uffelen K, Verstraeten AA, Snjdewint FG, van Kamp GJ, Schol DJ, Reis CA, Price MR, Livingston PO, Hilgers J: Reactivity of natural and induced humoral antibodies to MUC1 mucin with MUC1 peptides and n-actylgalactosamine (GalNAc) peptides. Int J Cancer 2000, 86: 703–712. 43. Silk AW, Schoen RE, Potter DM, Finn OJ: Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer. Mol Immunol 2009, in press. 44. Finn OJ: Cancer immunology.

Märgen, shortly after Glashütte coming from Hexenloch, MTB 8014/2

Märgen, shortly after Glashütte coming from Hexenloch, MTB 8014/2, 47°59′37″ N 08°07′32″ E, elev. 750 m, on hymenium of Fomitopsis pinicola on Picea abies, 2 Sep. 2004, H. Voglmayr & W. Jaklitsch, W.J. 2666 (WU 29431). Schramberg, Heiligenbronn, Schwarzwald, Spitalwald, on basidiome of Fomitopsis pinicola, 4 Oct. 2006, W. Gams, W.J. 3055 (WU 29436, OSI-906 concentration culture CBS 120643). Bavaria, Starnberg, Tutzing, Hartschimmel, Goaslweide, MTB 8033/3/1, 47°56′35″ N 11°11′02″ E, elev. 735 m, on hymenium of Fomitopsis pinicola, 22 Oct. 2003, P. Karasch, W.J. 2488 (WU 29430, culture C.P.K. 1992). Hessen, Eltville am Rhein, Hattenheim, forest at Geis, on Polyporus resinosus, identified as Fomitopsis pinicola, L. Fuckel, autumn,

Fungi Rhenani 2467 (M!). Italy, www.selleckchem.com/products/Nilotinib.html Südtirol, Pustertal, Sexten, Porzenwald, near Moos, MTB 9340/1, 46°40′34″ N 12°23′08″ E, elev. 1470 m, on Fomitopsis

pinicola, 1 Sep. 2000, W. Jaklitsch & H. Voglmayr. Sweden, Uppsala Län, Österbybruk, 3–4 km north from the town, right from the road to Forsmark, MTB 4373/4, 60°14′10″ N 17°55′41″ E, elev. 40 m, on hymenium of Fomitopsis pinicola on Picea abies, soc. Melanospora sp., Ophiostoma polyporicola, 4SC-202 datasheet scant material, 5 Oct. 2003, W. Jaklitsch, W.J. 2439 (WU 29427, culture C.P.K. 2395). Stockholms Län, Nothamn, forest at the east coast, MTB 4179/3, 60°01′45″ N 18°50′43″ E, elev. 10 m, on hymenium and upper part of Fomitopsis pinicola on Picea abies, 7 Oct. 2003, W. Jaklitsch, W.J. 2446 (WU 29428, culture C.P.K. 2397). Switzerland, Neuchatel, Lac de la Gruère, on basidiome of Fomitopsis pinicola, 10 Oct. 2006, Cyclic nucleotide phosphodiesterase W. Gams, W.J. 3056 (WU 29437, culture CBS 120640 = C.P.K. 2862). United Kingdom, Buckinghamshire, Slough, Burnham Beeches,

51°33′39″ N 00°37′55″ W, elev. 30 m, on hymenium of Piptoporus betulinus 23 cm diam, 15 Sep. 2007, W. Jaklitsch & H. Voglmayr, W.J. 3166 (WU 29439). Herefordshire, Leominster, Queenswood Country Park, Dinmore Hill, 52°09′13″ N 02°43′38″ W, elev. 150 m, on Piptoporus betulinus 2 m above ground on a standing trunk of Betula pendula, 11 Sep. 2007, W. Jaklitsch & H. Voglmayr, W.J. 3152 (WU 29438). Notes: This species is common and easily identified by ecological (growth on polypores) and morphological characteristics (unevenly distributed pigment, monomorphic ascospores, verrucose surface hairs, and lanceolate ostiolar cells). On Fomitopsis pinicola, H. pulvinata is often accompanied by H. protopulvinata; for differentiation see also under that species. To verify whether the fungus occurs on Laetiporus sulphureus (Polyporus sulphureus) and Ischnoderma resinosum (Polyporus resinosus), the lectotype from FH and the part of Fungi Rhenani 2467 from M were examined. In both specimens the host has a light to medium brown context and a resinous crust that melts in heat. This latter trait occurs only in basidiomata of Fomitopsis pinicola and uncommon species of Ganoderma, viz. G. pfeifferi and G. resinosum. The latter genus differs from Fomitopsis by a dark brown context.